Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

Compare

0.4718

+0.0113 (2.45%)

At close: Nov 7, 2025, 4:00 PM EST

0.4802

+0.0084 (1.78%)

After-hours: Nov 7, 2025, 7:58 PM EST

Sangamo Therapeutics Market Cap

Sangamo Therapeutics has a market cap or net worth of $142.35 million as of November 7, 2025. Its market cap has decreased by -55.61% in one year.

Market Cap

142.35M

Enterprise Value

138.15M

1-Year Change

-55.61%

Ranking

#4012

Market Cap Chart

Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from $314.10M to $142.35M, a decrease of -54.68%. That is a compound annual growth rate of -3.04%.

Market Cap History

Date	Market Cap	% Change
Nov 7, 2025	158.80M	-25.38%
Dec 31, 2024	212.80M	120.98%
Dec 29, 2023	96.30M	-81.29%
Dec 30, 2022	514.60M	-52.90%
Dec 31, 2021	1.09B	-50.50%
Dec 31, 2020	2.21B	127.45%
Dec 31, 2019	970.40M	-17.20%
Dec 31, 2018	1.17B	-15.45%
Dec 29, 2017	1.39B	543.50%
Dec 30, 2016	215.40M	-66.32%
Dec 31, 2015	639.50M	-38.53%
Dec 31, 2014	1.04B	21.20%
Dec 31, 2013	858.40M	169.51%
Dec 31, 2012	318.50M	113.76%
Dec 30, 2011	149.00M	-50.38%
Dec 31, 2010	300.30M	12.98%
Dec 31, 2009	265.80M	86.40%
Dec 31, 2008	142.60M	-72.71%
Dec 31, 2007	522.60M	133.30%
Dec 29, 2006	224.00M	118.75%
Dec 30, 2005	102.40M	-32.23%
Dec 31, 2004	151.10M	11.35%
Dec 31, 2003	135.70M	83.13%
Dec 31, 2002	74.10M	-67.54%
Dec 31, 2001	228.30M	-47.02%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	839.37B
Johnson & Johnson	450.47B
AbbVie	387.13B
UnitedHealth Group	291.28B
AstraZeneca	260.82B
Novartis AG	242.27B
Abbott Laboratories	217.27B
Merck & Co.	212.91B

Market Cap Rankings